Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neuroendocrine Tumor

Explore clinical trials studying Pancreatic Neuroendocrine Tumor. Study availability and eligibility vary by location and protocol.

36 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neuroendocrine Tumor trial results

Active, not recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Completed

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

NCT05997056

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +18 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Texas Oncology Dallas, Texas, United States
  • Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States
View Trial Details

Related conditions